Logo image of PNT

POINT BIOPHARMA GLOBAL INC (PNT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:PNT - US7305411099 - Common Stock

12.5 USD
+0.02 (+0.16%)
Last: 12/26/2023, 8:10:43 PM
12.51 USD
+0.01 (+0.08%)
After Hours: 12/26/2023, 8:10:43 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PNT revenue by date.PNT revenue by date.
226.6M20.448M
-90.98%
35.182M
72.06%
228.64M
549.88%
146.86M
-35.77%
365.44M
148.84%
649.09M
77.62%
476.94M
-26.52%
569.65M
19.44%
EBITDA
YoY % growth
PNT ebitda by date.PNT ebitda by date.
N/AN/A126.9M-125.24M
-198.69%
-142.41M
-13.71%
63.63M
144.68%
-138.37M
-317.46%
N/AN/AN/AN/A
EBIT
YoY % growth
PNT ebit by date.PNT ebit by date.
-13.1M-45.5M
-247.33%
125.5M
375.82%
-120.451M
-195.98%
-108.241M
10.14%
-15.595M
85.59%
-85.727M
-449.70%
54.341M
163.39%
205.09M
277.41%
145.62M
-29.00%
217.78M
49.55%
Operating Margin
PNT operating margin by date.PNT operating margin by date.
N/AN/A55.38%-589.06%-307.66%-6.82%-58.37%14.87%31.60%30.53%38.23%
EPS
YoY % growth
PNT eps by date.PNT eps by date.
N/AN/AN/A
-52.78%
-0.89
9.21%
-1.04
-15.99%
0.56
153.87%
-0.69
-223.67%
0.80
215.25%
1.87
134.50%
1.55
-17.15%
1.92
24.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth
-0.26
1.39%
-0.29
-81.80%
-0.30
-23.72%
-0.22
4.27%
-0.11
59.78%
-0.37
-28.47%
-0.37
-25.85%
-0.37
-69.72%
2.08
2,080.77%
-0.35
5.41%
-0.33
10.81%
-0.31
16.22%
Revenue
Q2Q % growth
2.289M
-98.99%
1.136M
-88.04%
1.136M
-76.82%
13.13M
368.93%
37.37M
1,532.59%
295.93M
25,950.18%
3.578M
214.96%
3.578M
-72.75%
284.08M
660.18%
2.562M
-99.13%
5.486M
53.33%
10.67M
198.21%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-33.46M
-117.48%
-33.498M
-48.88%
-34.447M
-9.35%
-22.077M
25.41%
1.214M
103.63%
-33.154M
1.03%
-33.154M
3.75%
-34.164M
-54.75%
-34.164M
-2,914.19%
N/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
-0.23
11.54%
-0.300.0724.55%
Q2 2023
Q2Q % growth
-0.24
11.11%
-0.300.0619.08%
Q1 2023
Q2Q % growth
-0.16
11.11%
-0.320.1649.55%
Q4 2022
Q2Q % growth

-65.53%
-0.26%
Q3 2022
Q2Q % growth
-0.26
-36.84%
-0.290.038.79%
Q2 2022
Q2Q % growth
-0.27
-80.00%
-0.22-0.05-20.42%
Q1 2022
Q2Q % growth
-0.18 -0.210.0315.13%
Q4 2021
Q2Q % growth
-0.16 -0.240.0832.59%
Q3 2021
Q2Q % growth
-0.19 -0.190.00-0.78%
Q2 2021
Q2Q % growth
-0.15 -0.11-0.04-35.01%
PNT Yearly EPS VS EstimatesPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
2.8M 897.779K1.902M211.88%
Q2 2023
Q2Q % growth
4.9M 953.884K3.946M413.69%
Q4 2022
Q2Q % growth
226.6M 26.26M200.34M762.91%
PNT Yearly Revenue VS EstimatesPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 14.94% 0% 12.19%
Revenue0% 83.86% 0% 25.31%